449 |
Bioabsorbable Polymer Based Paclitaxel Eluting Infinnium Stent for Multivessel Coronary Artery Disease: One Year Follow-Up Results of SIMPLE 3 Registry |
D.S. Gambhir |
May. 30. 08 |
448 |
Long Term Follow Up of DES and Bare Mental Stent in Chinese Single Center Experience |
Fang Chen |
May. 30. 08 |
447 |
Lesson Learned from The First National PCI Registry in Thailand |
Wacin Buddhari |
May. 30. 08 |
446 |
Can Routine IVUS Assessment (and RF Plaque Characterization) Reduce Stent Thrombosis and Restenosis? |
Gary S. Mintz |
May. 30. 08 |
445 |
When and How do I Use DES? Practical Clinical Considerations? Case Selection, Implantation Technique, and Anti-Platelet Therapy |
Antonio Colombo |
May. 30. 08 |
444 |
Do DES Increase or Decrease Mortality for "On-Label" and "Off-Label" Use Indications? |
David R. Holmes |
May. 30. 08 |
443 |
The Case for PCI as the Preferred Therapy in Most Patients with Chronic Stable Angina |
Ajay J. Kirtane |
May. 16. 08 |
442 |
Why Current DES Should NOT be Used Routinely During Primary AMI Angioplasty! |
Renu Virmani |
May. 16. 08 |
441 |
The Future Landscape of DES: New Stent Platforms, Drug Carriers, and Recent FIM Experiences |
Eberhard Grube |
May. 16. 08 |
440 |
The Interventional Trials of the Year: 2007-2008 (TCT, AHA, and ACC) |
Roxana Mehran |
May. 16. 08 |